Cryosite Limited (CTE.AX)

0.8400 +0.0100 (+1.20%) As of 11:40AM AEST. Market open.

Cryosite Limited

13a Ferndell Street
South Granville, NSW 2142
Australia
61 2 8865 2000
https://www.cryosite.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 25

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Jane Hao	Chief Financial Officer	195.34k	N/A	N/A
Mr. Jon Stearns	Operations Manager	N/A	N/A	N/A
Ms. Alicia Steel	Chief Quality Officer	N/A	N/A	N/A
Mr. Dray Andrea	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.

Corporate governance

Cryosite Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.